Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01917929 · ClinicalTrials.gov registry record · NA
Secur-Fit Advanced Outcomes Study
A NA study, sponsored by Stryker Orthopaedics.
- Terminated
- Registry status
- NA
- Development phase
- 326
- Enrollment target
NCT01917929: Clinical Trial NA study, sponsored by Stryker Orthopaedics.
NCT01917929 is a NA study that was terminated before completion, run by Stryker Orthopaedics. The registered enrollment target is 326 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01917929, a NA study, was terminated before completion, sponsored by Stryker Orthopaedics.
- TERMINATED
- Registry status
- NA
- Development phase
- 326 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate the Secur-Fit Advanced Hip Stem in primary total hip replacement surgery.
Primary Outcome
The primary objective is to determine the success rate at 5 years postoperative with the Secur-Fit Advanced Hip Stem in the cementless application. Success is defined as absence of femoral stem revision and/or removal for aseptic loosening or device-related femoral fracture at 5 years postoperative.
Interventions
- DEVICE Secur-Fit Advanced Hip Stem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 326 participants |
| Start Date | 2013-08-15 |
| Est. Completion | 2024-06-13 |
| Phase | NA |
Why NCT01917929 stopped before completion
NCT01917929 is an interventional study that assigns participants to a tested intervention. The registered 326 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 1 intervention - of which Secur-Fit Advanced Hip Stem is the first listed.
NCT01917929 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01917929 about?
NCT01917929 is a clinical study titled "Secur-Fit Advanced Outcomes Study". The goal of this study is to evaluate the Secur-Fit Advanced Hip Stem in primary total hip replacement surgery.
What is the current status of trial NCT01917929?
This trial is currently terminated. It is a NA study. The enrollment target is 326 participants. The study started on 2013-08-15. Estimated completion is 2024-06-13.
What interventions are being tested in trial NCT01917929?
The interventions under investigation include: Secur-Fit Advanced Hip Stem (DEVICE).
Who is sponsoring clinical trial NCT01917929?
This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01917929's enrollment target sits among peer trials
326 310th of 2000 higher than 1,690 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06410144 · 326 participants · NA
Chronic Kidney Disease-Education (CKD-EDU)
- NCT06586619 · 326 participants · NA
A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIV
- NCT07040566 · 326 participants · Phase 2
A Trial of Varenicline for E-cigarette Cessation
- NCT07165860 · 326 participants · NA
Clinical Trial to Reduce Perinatal Intimate Partner Violence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI